-
Zhangjiang Biopharmaceutical's three-year target of achieving sales revenue of 80 billion yuan in 2017
Time of Update: 2020-05-13
By 2017, Zhangjiang, as the main carrier to undertake Shanghai's construction of high-end biopharmaceutical product manufacturing center, innovation research and development center and medical service center in the Asia-Pacific region, continues
-
"2017 China's organs and enterprises employees metabolic health blue book" released Aikang joint right
Time of Update: 2020-05-12
November 12, on the occasion of the United Nations Diabetes Day (November 14), aikang Group and the National Center for Metabolic disease Clinical Medicine Research Center (Shanghai) Metabolic Big Data Strategic Cooperation
-
Diatom mud purchase: 2017 will start a new year with diatom mud decoration!
Time of Update: 2020-04-03
Core tip: now the economy is more and more developed, people have more and more material enjoyment, but the taste of the new year is becoming less and less
How can we
-
Diatom mud selection: how to choose diatom mud color? A list of popular colors in 2017
Time of Update: 2020-04-03
Many young women use light purple blue for home decoration, which is more warm than milky white wall.
-
Paint knowledge | 2017 cement floor paint price and construction technology
Time of Update: 2020-04-03
Cement floor paint is used to paint the ground to achieve a beautiful, flat, economic and practical effect.
-
Platelet aggregation inhibitors are in the Ascendant: tegrilol will become a "heavy bomb" in 2017. How about domestic declaration?
Time of Update: 2020-04-03
According to statistics, from October 2014 to September 2015, the global market size of platelet aggregation inhibitors is about 8.8 billion US dollars In US dollars, it decreased by 7% year-on-year, and increased by 3% year-on-year at fixed exchange rate.
-
Nanfang pharmaceutical a new type of new targeted nano Paclitaxel injection (Xinsu) is expected to complete preclinical research in 2017
Time of Update: 2020-04-03
It is a new injection developed independently by Nanfang pharmaceutical company, which combines modern polymer micelle technology with paclitaxel, an anti-tumor drug.
-
2017-2019 SFDA's inspection of overseas pharmaceutical enterprises
Time of Update: 2020-01-16
Text: zulikou431 As the leading pharmaceutical market in the world in terms of total volume, Chinese pharmaceutical market has always been concerned by overseas pharmaceutical
-
Nuolian helps building waterproof membrane manufacturers to meet new industry standards (JC / T 2415-2017)
Time of Update: 2019-11-21
At the 24th China International Coatings exhibition, nuolian announced the introduction of a new additive, Elotex (elatai) fx2325, to serve cement mortar manufacturers and help
-
Noleon helps building waterproof film manufacturers meet new industry standards (JC/T 2415-2017)
Time of Update: 2019-11-21
at the 24 China International Coatings Show, Noleon announced the launch of a new additive Elotex ® (Easy Thai ®) FX2325 , serving cement mortar manufacturers, to help them meet the new standards
-
June bidding monthly report: Gansu announced the 2017-2018 centralized mining winning results
Time of Update: 2019-07-12
Among them, the imported original research drugs are also listed in the drug catalog set It is the three reference preparations for consistency evaluation determined by the drug administration.
-
[perspective] from 1949 to 2017, "malignant lymphoma" has 41 therapeutic drugs in the world
Time of Update: 2018-12-19
According to the pathological classification, it can be divided into two categories: Hodgkin's lymphoma and non Hodgkin's lymphoma, which is a common type of adult malignant spleen tumor.
-
[exclusive] multiple myeloma: 20 drugs listed in 1959-2017, 9 domestic varieties entering the clinical practice
Time of Update: 2018-11-19
Multiple myeloma (MM) is a malignant clonal disease characterized by abnormal proliferation of bone marrow plasma cells
Only 25% of patients have chemotherapy after 5
-
Multiple myeloma: 20 domestic 9 kinds of drugs listed in 1959-2017 enter the clinical practice
Time of Update: 2018-11-19
Multiple myeloma (MM) is a malignant clonal disease characterized by abnormal proliferation of bone marrow plasma cells
Only 25% of patients have chemotherapy after 5
-
Seven pharmaceutical companies were selected in 2017 list of brand value of Shanghai and Shenzhen listed companies
Time of Update: 2018-10-26
In the first half of 2018, Shanghai Pharmaceutical's operating revenue was 75.9 billion yuan, a year-on-year increase of 15.35%; the net profit attributable to shareholders of listed companies was 2.03 billion yuan, a year-on-year increase of 5.62%.
-
2017 top 100 pharmaceutical brand enterprises of the Chinese nation publicized various key products to attract attention
Time of Update: 2018-09-11
[industry trends of China Pharmaceutical network] on September 8, the "2017 list of top 100 Chinese pharmaceutical brand enterprises and 2018 China traditional Chinese medicine
-
2017 blue book on the development of China's biomedical industry was officially released focusing
Time of Update: 2018-08-08
On August 6, 2018, Flint creation officially released the 2017 blue book on the development of China's biomedical industry
The blue book was compiled by flint creation
-
249 drug instructions have been revised since 2017
Time of Update: 2018-07-31
▍ 249 drug instructions have been revised since 2017, with an accelerated frequency trend Recently, the State Food and Drug Administration issued the notice of the State Food
-
"Report on health and people's health in Beijing 2017" released
Time of Update: 2018-07-11
The main cause of death of Beijing residents with household registration was still chronic non infectious diseases.
-
Comparison of target, indication and drug review of new antitumor drugs approved for market at home and abroad in 2017
Time of Update: 2018-06-28
The year's new drugs & biologics 2017, the latest new drug report released by corewellian, shows that 113 new chemical and biological drugs were approved for the first time
